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ABSTRACT
Objective: The goal of regenerative endodontic therapy is biological healing of the pulp tissue. It involves the disinfection of the canals with irrigants 
and medicaments. The medicaments that are currently used for this purpose are a triple antibiotic paste (TAP), calcium hydroxide (Ca[OH]2), and 
Ledermix®, a paste containing demeclocycline and triamcinolone. Therefore, the purpose of this study was to evaluate the effects of TAP, Ca(OH)2, and 
Ledermix® on the viability of dental pulp stem cells (DPSC).
Methods: Primary cultures of DPSC were obtained from immature third molars. Immunofluorescence assay using STRO-1 marker was performed 
to confirm the mesenchymal nature of the DPSC. The cells were exposed to TAP, Ca(OH)2, and Ledermix® at concentrations of 0.1 and 1 mg/mL. Cell 
viability was analyzed using the MTT assay.
Results: Significant differences in viability were noted between the cells exposed to the medicaments and those in the control group (p<0.05).
Conclusions: All three medicaments decreased the viability of DPSC, with the Ledermix® paste demonstrating the highest toxic effect.
Keywords: Dental pulp stem cells, Triple antibiotic paste, Calcium hydroxide, Ledermix®, Cell viability. 
INTRODUCTION
The ultimate goal of endodontic treatment is the achievement of 
biological healing in the form of regeneration. Network regeneration 
is the process of healing by restoring the natural architecture 
and biological functions of damaged tissue, whereas repair is the 
restoration of tissue with replacement or scar tissue, without the return 
of function [1]. Regeneration restores the vitality of the tooth so that it 
can function like a healthy tooth. However, the conventional endodontic 
treatment procedures performed currently replace damaged tissue 
with biocompatible synthetic materials, but do not restore the biological 
functions to resemble that of normal tissues [2].
The development of science and network engineering technology 
is proving to be a breakthrough in the field of endodontics with the 
inclusion of stem cells, growth factors, and scaffolds, which are known 
as the triad of endodontic engineering. The first element of the tissue 
engineering triad is the stem cells. Studies on the isolation of dental 
stem cells have developed rapidly, especially after its isolation in pulp 
stem cells in 2000 [3]. Dental pulp stem cells (DPSC) have a high rate 
of proliferation even after many subcultures. In addition, DPSC have 
the ability to modify due to its high rate of differentiation. DPSC are 
present along with stem cells of apical papilla (SCAP) in the open 
apex; therefore, they continue to carry the morphogenetic information 
derived from SCAP. The characteristics and multiline differentiation 
potential of DPSC make them an important part of regenerative care [4].
Regenerative endodontic treatment has been a promising alternative 
treatment for the treatment of immature teeth with pulpal necrosis [5,6] 
and can replace conventional endodontic treatment methods when 
used in conjunction with tissue engineering [7-9]. This will shift the 
paradigm of endodontic treatment from conventional/reparative to 
regenerative [1,10].
Numerous studies on regenerative endodontics using successful 
revascularization procedures in immature teeth with pulp necrosis and 
continued bleeding into the canal system due to over-instrumentation 
have been published so far [1,5]. The most important aspect of this 
clinical procedure is the chemical disinfection of the root canal system 
using irrigation materials and root canal medicaments for several 
weeks [5,6]. Root canal medicaments should ideally have antibacterial 
properties and provide a conducive environment so that stem cells 
can regenerate or heal [11,12]. Therefore, the concentration of the 
medicaments used in regenerative endodontic procedures should be 
effective against bacteria but not toxic to the stem cells [6].
METHODS
The study protocol had been approved by the Dental Research Ethics 
Committee, Faculty of Dentistry, Universitas Indonesia. Mesenchymal 
stem cells from the pulp of immature permanent third molars with open 
apices (primary culture) were used in this study. Inclusion criteria were 
as follows: Permanent third molar teeth indicated for extraction, from 
male or female patients aged <20 years, with radiographic evidence of 
immature teeth with open apices (>1.5 mm) during the development 
stage. The exclusion criteria were as follows: Permanent third molars 
with caries or pulp and periapical disease, cultures contaminated with 
fungi/bacteria, and cells that did not grow well during the first and 
subsequent passages.
Primary cells were isolated from newly extracted immature third molar 
teeth. Pulp tissue was removed, chopped into 2 mm×2 mm×1 mm 
fragments and incubated in a Petri dish with 0.25% trypsin for 5 min. 
The cells were added into 6-well plates containing complete Dulbecco’s 
modified Eagle’s medium and incubated at 37°C and 5% CO2 until 
confluent.
For the immunofluorescence test, cells were plated in chamber slides 
at a density of 5000 cells and incubated at 37°C and 5% CO2 for 
3 days. On day 3, the medium was removed, and the cells were fixed 
using acetone-methanol absolute solution for 2 min. After fixation, the 
cells were washed with PBS solution and dried. Primary antibodies 
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were dissolved in PBS at concentrations of 100%, 50%, and 25%, and 
100 μL was added into each chamber. The cells were incubated with the 
antibodies at 37°C for 60 min; following which, they were washed again 
with PBS solution. Secondary antibody fluorescein isothiocyanate was 
added, and the cells were incubated at 37°C for 60 min. After washing 
with PBS, the cells were dyed with Evans Blue, rinsed with aquabidest, 
and dried. Subsequently, the cell specimens were observed under a 
fluorescence microscope.
The cells were divided into two groups, control and treatment cells 
exposed to the test materials triple antibiotic paste (TAP), Ledermix®, 
a paste containing demeclocycline and triamcinolone, and pure 
calcium hydroxide powder (Ca[OH]2), at concentrations of 0.1 and 
1 mg/mL.
TAP was prepared by mixing 500 mg of metronidazole (Indofarma, 
Indonesia), 200 mg of ciprofloxacin (Bernofarm, Indonesia), and 
100 mg of doxycycline (OGB Dexa, Indonesia) at a 1:1:1 ratio (3Mix) and 
added to a mixture of macrogol (M) and propylene glycol (P; ratio, 1:1), 
which acted as the solvent (MP). The antibiotic mixture and the solvent 
were stirred evenly until a putty consistency was achieved. A (OH)2 
paste was prepared by mixing Ca[OH]2 powder (Merck, Germany) 
with aquadest to form a sandy paste-like consistency. TAP, Ledermix® 
(Riemser Pharma GmbH, Germany), and Ca(OH)2 pastes were diluted in 
the medium to concentrations of 0.1 and 1 mg/mL.
For the MTT test, the cells were incubated in 96-well plates for 24 h. 
The cell culture medium was discarded, and 100 μL of test material 
was added per well. The cells were incubated at 37°C and 5% CO2 for 
48 h. MTT compound (100 μL) was added, and the cells were incubated 
at 37°C and 5% CO2 for 4 h. The cell supernatant was removed, and 
the formazan crystals formed were dissolved in 70% ethanol. Optical 
density (OD) readings were obtained using a microplate reader at a 
wavelength of 595 nm.
The data obtained were analyzed by one-way analysis of variance and 
post hoc Bonferroni’s tests with a 95% confidence interval to compare 
the OD values between the control group and the treatment group.
RESULTS
An immunofluorescence test was performed using the STRO-1 antibody 
to confirm the mesenchymal nature of the primary culture cells from 
the dental pulp. Microscopic picture of the test results is shown in Fig. 1.
The figure above shows a red cell image with no primary antibody 
attached to the cell antigen. Thus, secondary antibodies cannot react 
with the primary antibody and produce a green luminescence. On 
the other hand, green luminescence indicates that the cell is positive 
against STRO-1 and is a mesenchymal stem cell.
Microscopic images of the cells in the control and treatment groups 
after incubation for 2 days on a 96-well plate are shown in Figs. 2-5.
Fig. 2 shows the microscopic images of the control cell cultures that 
were not exposed to bioactive compounds. Numerous, evenly dispersed 
fibroblasts presenting as small spindle-shaped cells with a thin 
cytoplasmic extension were noted. Microscopic images of cells in the 
TAP group revealed shortened cells that were in fewer numbers when 
compared with the control group (Fig. 3). The morphology of cells in 
the Ledermix® treatment group was also altered, and the numbers 
were reduced (Fig. 4), whereas in the Ca(OH)2 treatment group the 
morphology of the cells was similar to that in the control group with a 
sufficiently high number of cells (Fig. 5).
The OD was measured in the MTT assay, and the values were 
expressed as a percentage of the control group. The mean OD values 
and percentages of cell viability are shown in Table 1, whereas Table 2 
illustrates the significant differences in cell viability between the 
treatment and control groups.
The highest value of cell viability among the cell groups exposed to the 
0.1 mg/mL of the test material was noted with Ca(OH)2 (45.5% ± 5.8%), 
and the lowest was noted with Ledermix® (15.1% ± 3.4%). TAP was 
the most effective in reducing the viability of cells exposed to 1 mg/mL 
concentration of the test material, whereas Ledermix® appeared to be 
the least effective (Table 1).
The cell viability in all treatment groups was significantly lower than that 
of the control group at concentrations of both 0.1 and 1 mg/mL (p<0.05).
Fig. 2: Microscopic image of control cells in medium after 
incubation for 2 days (×32 magnification)
Fig. 3: Microscopic images of the triple antibiotic paste 
(TAP) treatment group cells after incubation for 2 days 
(×32 magnification). Treatment group exposed to TAP at a 
concentration of 0.1 mg/mL (a) and 1 mg/mL (b)
ba
Fig. 1: Microscopic images of the immunofluorescence test 
results. (a) Control group, primary antibody STRO-1 was not 
added; (b) Group I, primary antibody added without dilution; 
(c) Group II, primary antibody added with ×2 dilution; and 
(d) Group III, primary antibody added with ×4 dilution
dc
ba
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Table 3 presents the differences in cell viability among the three 
treatment groups exposed to the test material at concentrations of 0.1 
and 1 mg/ml. Statistically significant differences were not observed 
in the TAP treatment group, whereas both Ledermix® and Ca(OH)2 
treatment groups showed statistically significant differences between 
the two concentrations of the test material used in this study (p<0.05).
Table 4 shows that the viability of cells in the TAP group was 
significantly higher than that of the Ledermix® group when exposed 
to the test material at concentrations of 0.1 mg/mL (42.8% vs. 15.1%) 
and 1 mg/mL (37.2% vs. 7.4%), respectively (p<0.05). Similarly, the 
cell viability ratio of the Ca(OH)2 treatment group at all concentrations 
was significantly higher than that of the Ledermix® group (p<0.05), 
but lower than that of the TAP treatment group (statistical significance 
notwithstanding).
DISCUSSION
The purpose of endodontic regeneration is the achievement of biological 
recovery, which reproduces the natural architecture and original 
biological functions of the tissue. A crucial stage in this treatment is the 
chemical disinfection of the root canal system by irrigation and placing 
of medicaments in the root canal for several weeks to kill bacteria 
and germs that are still present deep within the dentinal tubules. 
Very few studies on endodontic regeneration have been conducted in 
Indonesia; hence, this study aimed to evaluate the effects of root canal 
medicaments commonly used in root canal treatment on the viability of 
mesenchymal stem cells.
In this study, the primary culture of mesenchyme DPSC was used on 
the basis of the study by Pérez et al. (2003), who reported that the 
results of primary cells used to test an endodontic material would be 
much closer to the actual condition when compared with secondary 
cells [13]. SCAP is commonly used in regenerative studies because it 
has a higher proliferative capacity when compared with DPSC [14]. 
Nonetheless, we used DPSC in the current study because they carry 
morphogenetic information derived from SCAP. DPSC is an integral part 
of SCAP and is separated by an apical cell-rich zone at the odontogenesis 
stage, especially in immature teeth with incompletely closed root 
apices [15]. Chuensombat et al. (2013) reported that the survival of 
DPSC in infected root canals indicates their ability to regenerate [16]. 
Moreover, the volume of DPSC is 10 times higher than that of primary 
cells from SCAP, whereas the levels of contamination are lower because 
it is more coronally located, thus minimizing the risk of contact with the 
external environment at the time of collection.
There is heterogeneity in the mesenchymal stem cell population, 
with cells expressing different molecular markers. DPSC is an 
adult mesenchymal stem cell that can be characterized in vitro 
by STRO-1 [14,17,18], a monoclonal antibody that marks the 
subpopulation of mesenchymal stem cells as a colony-forming unit 
fibroblast because the morphology of mesenchymal stem cells 
resembles that of fibroblasts in vitro [19,20]. The selection of STRO-
1 as a DSPC molecular marker in this study is based on previous 
studies, which demonstrated the consistent specificity of STRO-1 as a 
mesenchymal stem marker [18,21]. In the present study, STRO-1 was 
detected on DPSC using the indirect immunofluorescence test method. 
Table 1: Mean optical density values and percentages of cell 
viability between the control and treatment groups













OD: Optical density, TAP: Triple antibiotic paste, SD: Standard deviation, 
Ca(OH)2: Calcium hydroxide 
Table 2: Significance differences in cell viability between the 
treatment and control groups at concentrations of 0.1 mg/mL 









0.1 mg/ml 0.001* 0.000* 0.001*
1 mg/ml 0.015* 0.000* 0.001*
*p<0.05. Ca(OH)2: Calcium hydroxide, TAP: Triple antibiotic paste
Table 3: Differences in cell viability among the three treatment 
groups exposed to the test material at concentrations of 0.1 and 
1 mg/mL (p<0.05)




*p<0.05. Ca(OH)2: Calcium hydroxide, TAP: Triple antibiotic paste
Fig. 5: Microscopic images of calcium hydroxide (Ca(OH)2) 
treatment group cells after incubation for 2 days (×32 
magnification). Treatment group exposed to Ca(OH)2 at a 
concentration of 0.1 mg/mL (a) and 1 mg/mL (b)
ba
Fig. 4: Microscopic images of the Ledermix® treatment group 
cells after incubation for 2 days (×32 magnification). Treatment 
groups exposed to Ledermix® at a concentration of 0.1 mg/mL 
(a) and 1 mg/mL (b)
ba
Table 4: Differences in cell viability among the TAP, Ledermix®, 
and Ca(OH)2 treatment groups based on the concentration of 
the test materials (p<0.05)






0.1 mg/ml 0.002* 1.000 0.000*
1 mg/ml 0.000* 1.000 0.004*
*p<0.05. Ca(OH)2: Calcium hydroxide, TAP: Triple antibiotic paste
 The 3rd International Conference on Global Health (ICGH), Universitas Indonesia, Bali, Indonesia 52
Int J App Pharm, Vol 11, Special Issue 1, 2019
 Prasanti et al. 
Immunofluorescence is a histochemical staining technique that uses 
antigen-antibody reactions, where antibodies are characterized by a 
fluorescent dye and the antigen-antibody complex is visualized using 
a fluorescence microscope. The indirect immunofluorescence method 
was used because the signal amplification of secondary antibodies that 
bind to each primary antibody results in higher sensitivity [22-24].
There are several methods to test the cytotoxicity of a bioactive 
substance/compound. The cell viability parameter used in this study 
was the MTT test because it has a high sensitivity in evaluating the 
cytotoxicity of the test material; moreover, the steps used to conduct 
this procedure are relatively fast and easy to re-perform if necessary. 
This method is used to measure the metabolic activity of cell growth 
after exposure to the test material. The basic principle is to measure 
cellular activity based on the ability of succinate dehydrogenase in the 
mitochondria of the cell to reduce the MTT salts. This enzyme reacts 
with MTT and forms purple formazan crystals. The amount of formazan 
crystals formed is proportional to the activity of the living cells because 
these crystals are impermeable to cell membranes [25,26].
Cell viability in the treatment group was lower than that in the 
control group (Tables 1 and 2). Thus, the first hypothesis that TAP and 
Ledermix® can decrease the viability of DPSC was accepted, whereas 
the second hypothesis that Ca[OH]2 can increase the viability of DPSC 
was rejected.
The viability of cells in the TAP group at concentrations of 0.1 and 
1 mg/mL was significantly lower when compared with that in the 
control group. These results are consistent with those reported by 
Chuensombat et al. (2013), where TAP had a toxic effect on pulp and 
apical papilla cells at a concentration of 25 μg/mL. This is due to the low 
pH of the TAP (4–4.6), caused by the release of hydrogen ions from the 
hydrochloride group in minocycline hydrochloride and ciprofloxacin 
hydrochloride, thus causing unfavorable acidic conditions in the cell 
culture. The low pH also maintains TAP solubility enabling it to enter the 
cell, thereby increasing its cytotoxicity. It is known that metronidazole 
has no toxic properties due to its neutral pH [16]. Therefore, alternative 
antibiotics with neutral pH and potent antibacterial properties, instead 
of minocycline and ciprofloxacin, should be selected.
As seen in Table 1, the cell viability values in the Ledermix® treatment 
group were very low (<30%) and may be included in the high toxicity 
category based on the Dahl et al. criteria [27]. The decrease in cell 
viability with a concentration of 1 mg/mL Ledermix® was significantly 
higher than that with a concentration of 0.1 mg/mL. This finding is 
supported by Taylor et al. (1989) who reported that Ledermix® can kill 
mouse fibroblast cells at very low concentrations of 0.001 mg/mL [28]. 
The cytotoxic properties of Ledermix®, especially the corticosteroid 
component, are exerted by inhibiting phagocytosis and DNA/proteins 
synthesis during the cell mitosis process. Thus, cell replication is 
inhibited, and the healing process is impaired [28,29]. This was 
evidenced by Oliveira et al. (2009) who used mouse pulp cells exposed to 
antibiotic-corticosteroids (Otosporin®) for 72 h to demonstrate delays 
in tissue healing after treatment [30]. However, Taylor et al. (1989) 
stated that the toxic effects can be inhibited by mixing with Pulpdent® 
(Ca[OH]2) [28]. These findings indicate that the use of Ledermix® as a 
medicament in regenerative endodontics should be avoided as it may 
interfere with the cell regeneration process. Alternatively, they may be 
used at very low concentrations or in conjunction with Ca[OH]2.
The viability values of cells exposed to 0.1 or 1 mg/mL Ca(OH)2 was 
also decreased when compared with the control group. This may be 
attributed to the high pH of the Ca(OH)2 (2.5–12.8), which can cause 
cell/tissue necrosis immediately after contact, thus destroying cells 
that have the potential to regenerate [31]. Giro et al. (2010) examined 
the effects of Ca[OH]2 on pulp cells during the direct pulp capping 
procedure and observed a layer of coagulation necrosis under the 
capping agent in all treatment groups after 7 days; however, pulp cells 
were still present within the necrotic tissue with very few infiltrates 
of inflammatory cells [32]. Subsequently, after 30 days, the specimens 
showed normal elongation of the monolayer cells associated with hard 
tissue deposition near the wound area, thus implying that Ca(OH)2 
can be used over a long period of time. The formation of mineralized 
tissue after contact with Ca[OH]2 can be seen on the 7th–10th day after 
application of the compound. In the present study, incubation after 
exposure of the test material was only for 2 days. The duration of 
this exposure was based on the number of cells planted (as many as 
5000 cells) in the 96 well plates to achieve confluence within 48 h.
The test material used in this study was dissolved in the culture medium 
until the concentrations of 0.1 and 1 mg/mL were obtained. These 
concentration values were selected on the basis of a previous study 
by Ruparel et al. (2012), which states that TAP concentrations above 
1 mg/mL have a lethal effect [6]. The concentrations of the test material 
were effective in reducing cell viability, especially in the Ledermix® 
and Ca(OH)2 treatment groups, in the current study. However, in the 
TAP treatment group, the decrease in cell viability was not statistically 
significant. This contradicts with the results of the aforementioned 
study, where concentrations of 1 mg/mL TAP had a toxic effect, 
whereas, at a concentration of 0.1 mg/mL, no detectable toxic effect was 
noted; on the other hand, Ca(OH)2 at high concentrations (100 mg/mL) 
increased cell proliferation [6]. These differences in results may be due 
to the different methods used, wherein a cell insert was used by Ruparel 
et al. so that the material did not come in direct contact with the cell, 
whereas in the present study, we used the direct contact method. The 
use of direct contact simulates the clinical setting where the root canal 
medication used in current endodontic treatment needs to be in direct 
contact to be more effective.
The root canal medicaments that were least effective in decreasing cell 
viability were TAP and Ca(OH)2. Statistical significance notwithstanding, 
the cell viability value in the TAP group (concentration, 0.1 mg/ml) was 
lower than that of Ca(OH)2 at a concentration of 0.1 mg/mL; on the other 
hand, the cell viability value in the TAP group (concentration, 1 mg/mL) 
was higher than that of Ca(OH)2 at a concentration of 1 mg/mL. These 
findings indicate that TAP and Ca(OH)2 have the same effects on the 
viability of DPSC cells.
The three root canal medicaments, TAP, Ledermix®, and Ca(OH)2, 
were found to decrease the viability of dental pulp mesenchymal stem 
cells. The results of this in vitro study, which was purely a cellular 
study, cannot be compared directly with those of other in vivo studies. 
However, it is important to focus on the concentration of and duration 
of exposure to the medicinal ingredients before selection for use in 
regenerative care; the medicaments must be effective against bacteria 
and not cytotoxic for the stem cells. In addition, further in vivo studies 
in animals and humans are required to re-evaluate the cytotoxicity and 
biocompatibility of these medicaments.
CONCLUSIONS
From this study, it can be concluded that the root canal medicaments 
TAP, Ledermix®, and Ca(OH)2 can decrease the viability of stem cells 
obtained from the pulp mesenchyme. TAP and Ca(OH)2 are the least 
effective in reducing cell viability, whereas Ledermix® has the highest 
effect in decreasing the viability of the stem cells of the pulp.
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